216 related articles for article (PubMed ID: 19887478)
1. Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival.
Conway C; Mitra A; Jewell R; Randerson-Moor J; Lobo S; Nsengimana J; Edward S; Sanders DS; Cook M; Powell B; Boon A; Elliott F; de Kort F; Knowles MA; Bishop DT; Newton-Bishop J
Clin Cancer Res; 2009 Nov; 15(22):6939-46. PubMed ID: 19887478
[TBL] [Abstract][Full Text] [Related]
2. Melanoma sentinel node biopsy and prediction models for relapse and overall survival.
Mitra A; Conway C; Walker C; Cook M; Powell B; Lobo S; Chan M; Kissin M; Layer G; Smallwood J; Ottensmeier C; Stanley P; Peach H; Chong H; Elliott F; Iles MM; Nsengimana J; Barrett JH; Bishop DT; Newton-Bishop JA
Br J Cancer; 2010 Oct; 103(8):1229-36. PubMed ID: 20859289
[TBL] [Abstract][Full Text] [Related]
3. Patterns of expression of DNA repair genes and relapse from melanoma.
Jewell R; Conway C; Mitra A; Randerson-Moor J; Lobo S; Nsengimana J; Harland M; Marples M; Edward S; Cook M; Powell B; Boon A; de Kort F; Parker KA; Cree IA; Barrett JH; Knowles MA; Bishop DT; Newton-Bishop J
Clin Cancer Res; 2010 Nov; 16(21):5211-21. PubMed ID: 20705614
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform.
Abramovitz M; Barwick BG; Willis S; Young B; Catzavelos C; Li Z; Kodani M; Tang W; Bouzyk M; Moreno CS; Leyland-Jones B
Br J Cancer; 2011 Nov; 105(10):1574-81. PubMed ID: 22067903
[TBL] [Abstract][Full Text] [Related]
6. The role of osteopontin expression in melanoma progression.
Kiss T; Ecsedi S; Vizkeleti L; Koroknai V; Emri G; Kovács N; Adany R; Balazs M
Tumour Biol; 2015 Sep; 36(10):7841-7. PubMed ID: 25944164
[TBL] [Abstract][Full Text] [Related]
7. A multimarker prognostic assay for primary cutaneous melanoma.
Kashani-Sabet M; Venna S; Nosrati M; Rangel J; Sucker A; Egberts F; Baehner FL; Simko J; Leong SP; Haqq C; Hauschild A; Schadendorf D; Miller JR; Sagebiel RW
Clin Cancer Res; 2009 Nov; 15(22):6987-92. PubMed ID: 19887476
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin as a molecular prognostic marker for melanoma.
Rangel J; Nosrati M; Torabian S; Shaikh L; Leong SP; Haqq C; Miller JR; Sagebiel RW; Kashani-Sabet M
Cancer; 2008 Jan; 112(1):144-50. PubMed ID: 18023025
[TBL] [Abstract][Full Text] [Related]
9. BET inhibitor suppresses melanoma progression
Deng G; Zeng F; Su J; Zhao S; Hu R; Zhu W; Hu S; Chen X; Yin M
Theranostics; 2020; 10(25):11428-11443. PubMed ID: 33052224
[No Abstract] [Full Text] [Related]
10. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.
Hoek K; Rimm DL; Williams KR; Zhao H; Ariyan S; Lin A; Kluger HM; Berger AJ; Cheng E; Trombetta ES; Wu T; Niinobe M; Yoshikawa K; Hannigan GE; Halaban R
Cancer Res; 2004 Aug; 64(15):5270-82. PubMed ID: 15289333
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.
Sadi AM; Wang DY; Youngson BJ; Miller N; Boerner S; Done SJ; Leong WL
BMC Cancer; 2011 Jun; 11():253:1-13. PubMed ID: 21679412
[TBL] [Abstract][Full Text] [Related]
12. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
[TBL] [Abstract][Full Text] [Related]
13. Is nonmetastatic cutaneous melanoma predictable through genomic biomarkers?
Branca M; Orso S; Molinari RC; Xu H; Guerrier S; Zhang Y; Mili N
Melanoma Res; 2018 Feb; 28(1):21-29. PubMed ID: 29194095
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay.
Waddell N; Cocciardi S; Johnson J; Healey S; Marsh A; Riley J; da Silva L; Vargas AC; Reid L; ; Simpson PT; Lakhani SR; Chenevix-Trench G
J Pathol; 2010 Aug; 221(4):452-61. PubMed ID: 20593485
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas.
Bachmann IM; Ladstein RG; Straume O; Naumov GN; Akslen LA
BMC Cancer; 2008 Dec; 8():362. PubMed ID: 19061491
[TBL] [Abstract][Full Text] [Related]
16. Melanoma MicroRNA signature predicts post-recurrence survival.
Segura MF; Belitskaya-Lévy I; Rose AE; Zakrzewski J; Gaziel A; Hanniford D; Darvishian F; Berman RS; Shapiro RL; Pavlick AC; Osman I; Hernando E
Clin Cancer Res; 2010 Mar; 16(5):1577-86. PubMed ID: 20179230
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.
Rangel J; Torabian S; Shaikh L; Nosrati M; Baehner FL; Haqq C; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M
J Clin Oncol; 2006 Oct; 24(28):4565-9. PubMed ID: 17008696
[TBL] [Abstract][Full Text] [Related]
18. Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.
Gradilone A; Gazzaniga P; Ribuffo D; Scarpa S; Cigna E; Vasaturo F; Bottoni U; Innocenzi D; Calvieri S; Scuderi N; Frati L; Aglianò AM
J Clin Oncol; 2003 Jan; 21(2):306-12. PubMed ID: 12525523
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling.
Glud M; Klausen M; Gniadecki R; Rossing M; Hastrup N; Nielsen FC; Drzewiecki KT
J Invest Dermatol; 2009 May; 129(5):1219-24. PubMed ID: 19005486
[TBL] [Abstract][Full Text] [Related]
20. Plasma osteopontin concentrations in patients with cutaneous melanoma.
Filia A; Elliott F; Wind T; Field S; Davies J; Kukalizch K; Randerson-Moor J; Harland M; Bishop DT; Banks RE; Newton-Bishop JA
Oncol Rep; 2013 Oct; 30(4):1575-80. PubMed ID: 23934016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
